|
1
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263.
2024.PubMed/NCBI
|
|
2
|
Rudin CM, Brambilla E, Faivre-Finn C and
Sage J: Small-cell lung cancer. Nat Rev Dis Primers. 7:32021.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shields CL, Kalafatis NE, Gad M, Sen M,
Laiton A, Silva AMV, Agrawal K, Lally SE and Shields JA: Metastatic
tumours to the eye. Review of metastasis to the iris, ciliary body,
choroid, retina, optic disc, vitreous, and/or lens capsule. Eye
(Lond). 37:809–814. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shields CL, Welch RJ, Malik K,
Acaba-Berrocal LA, Selzer EB, Newman JH, Mayro EL, Constantinescu
AB, Spencer MA, McGarrey MP, et al: Uveal metastasis: Clinical
features and survival outcome of 2214 tumors in 1111 patients based
on primary tumor origin. Middle East Afr J Ophthalmol. 25:81–90.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kur J, Newman EA and Chan-Ling T: Cellular
and physiological mechanisms underlying blood flow regulation in
the retina and choroid in health and disease. Prog Retin Eye Res.
31:377–406. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jager MJ, Shields CL, Cebulla CM,
Abdel-Rahman MH, Grossniklaus HE, Stern MH, Carvajal RD, Belfort
RN, Jia R, Shields JA and Damato BE: Uveal melanoma. Nat Rev Dis
Primers. 6:242020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jouhi S, Al-Jamal RT, Täll M, Eskelin S
and Kivelä TT: Presumed incipient choroidal melanoma: Proposed
diagnostic criteria and management. Br J Ophthalmol. 107:412–417.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mahajan A, Crum A, Johnson MH and Materin
MA: Ocular neoplastic disease. Semin Ultrasound CT MR. 32:28–37.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zugazagoitia J and Paz-Ares L:
Extensive-stage small-cell lung cancer: First-line and second-line
treatment options. J Clin Oncol. 40:671–680. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
McKeage MJ: Lobaplatin: A new antitumour
platinum drug. Expert Opin Investig Drugs. 10:119–128. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Oken MM, Creech RH, Tormey DC, Horton J,
Davis TE, McFadden ET and Carbone PP: Toxicity and response
criteria of the eastern cooperative oncology group. Am J Clin
Oncol. 5:649–655. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Farrar JT, Young JP Jr, LaMoreaux L, Werth
JL and Poole MR: Clinical importance of changes in chronic pain
intensity measured on an 11-point numerical pain rating scale.
Pain. 94:149–158. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shah SU, Mashayekhi A, Shields CL, Walia
HS, Hubbard GB III, Zhang J and Shields JA: Uveal metastasis from
lung cancer: Clinical features, treatment, and outcome in 194
patients. Ophthalmology. 121:352–357. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gerba-Górecka K, Romanowska-Dixon B,
Karska-Basta I, Cieplińska-Kechner E and Nowak MS: Clinical
characteristics and management of ocular metastases. Cancers
(Basel). 17:10412025. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li H, Luo J, Feng Z, Maberley D, Li Y, Wei
W and Liu Y: Uveal metastasis: Clinical characteristics, treatment,
and prognostic factors in a cohort of 161 patients in China. Can J
Ophthalmol. Jan 13–2025.(Epub ahead of print). doi:
10.1016/j.jcjo.2024.12.002. View Article : Google Scholar
|
|
17
|
Arepalli S, Kaliki S and Shields CL:
Choroidal metastasis: Origin, features, and therapy. Indian J
Ophthalmol. 63:122–127. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jardel P, Sauerwein W, Olivier T,
Bensoussan E, Maschi C, Lanza F, Mosci C, Gastaud L, Angellier G,
Marcy PY, et al: Management of choroidal metastases. Cancer Treat
Rev. 40:1119–1128. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Massagué J and Ganesh K:
Metastasis-initiating cells and ecosystems. Cancer Discov.
11:971–994. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nguyen DX and Massagué J: Genetic
determinants of cancer metastasis. Nat Rev Genet. 8:341–352. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fernandes BF, Fernandes LH and Burnier MN
Jr: Choroidal mass as the presenting sign of small cell lung
carcinoma. Can J Ophthalmol. 41:605–608. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Aichouni N, Ziani H, Kamaoui I, Nasri S
and Skiker I: Choroidal metastasis revealing a lung adenocarcinoma:
A case report. Cureus. 13:e189682021.PubMed/NCBI
|
|
23
|
Singh N, Kulkarni P and Aggarwal AN:
Clinical manifestation and outcome of lung cancer patients with
ocular metastasis: 16 Case reports and system of the literature.
Medicine (Baltimore). 91:179–194. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Qu Z, Liu J, Zhu L and Zhou Q: A
comprehensive understanding of choroidal metastasis from lung
cancer. Onco Targets Ther. 14:4451–4465. 2012. View Article : Google Scholar
|
|
25
|
Liu Y, Feng X, Xu Y, Yu S and Wang M:
Clinical manifestation and outcome of lung cancer patients with
ocular metastasis: 16 Case reports and systematic review. Thorac
Cancer. 15:2147–2155. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
John VJ, Jacobson MS and Grossniklaus HE:
Bilateral choroidal metastasis as the presenting sign of small cell
lung carcinoma. J Thorac Oncol. 5:12892010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Anwar J, Amin T, Sarfraz Z, Khalid M, Khan
MS and Abdelhakeem A: Unilateral choroidal metastases as an unusual
presentation of small cell lung cancer. Proc (Bayl Univ Med Cent).
37:870–873. 2024.PubMed/NCBI
|
|
28
|
Dabouz R, Abram P, Rivera JC and Chemtob
S: Mast cells promote choroidal neovascularization in a model of
age-related macular degeneration. J Neuroinflammation. 21:2472024.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Janetos TM, Volpe NJ and Simon SS:
Neuro-ophthalmic manifestations of cancer: A narrative review. Chin
Clin Oncol. 11:252022. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lin P and Mruthyunjaya P: Retinal
manifestations of oncologic and hematologic conditions. Int
Ophthalmol Clin. 52:67–91. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Baldwin KJ, Zivković SA and Lieberman FS:
Neurologic emergencies in patients who have cancer: Diagnosis and
management. Neurol Clin. 30:101–128. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yue Y, Ren Y, Lu C, Jiang N, Wang S, Fu J,
Kong M and Zhang G: The research progress on meningeal metastasis
in solid tumors. Discov Oncol. 16:2542025. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bouhlel L, Hofman V, Maschi C, Ilié M,
Allégra M, Marquette CH, Audigier-Valette C, Thariat J and Hofman
P: The liquid biopsy: A tool for a combined diagnostic and
theranostic approach for care of a patient with late-stage lung
carcinoma presenting with bilateral ocular metastases. Expert Rev
Anticancer Ther. 17:1087–1092. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Konstantinidis L and Damato B: Intraocular
metastases-a review. Asia Pac J Ophthalmol (Phila). 6:208–214.
2017.PubMed/NCBI
|
|
35
|
Maller B, Salvatori S and Tanvetyanon T:
Outcomes of intraocular metastasis from lung cancer in the era of
targeted therapy: A systematic review and pooled analysis. Clin
Lung Cancer. 23:e519–e525. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bolletta E, De Simone L, Pellegrini M,
Preziosa C, Mastrofilippo V, Adani C, Gentile P, Gozzi F and Cimino
L: Optical coherence tomography in inflammatory and neoplastic
lesions deforming the choroidal profile. Diagnostics (Basel).
13:19912023. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Qu Z, Liu J, Zhu L and Zhou Q: Clinical
features and treatment modalities of rare choroid metastasis from
lung malignancy. Chin Med J (Engl). 135:1628–1630. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bianciotto C, Shields CL, Guzman JM,
Romanelli-Gobbi M, Mazzuca D Jr, Green WR and Shields JA:
Assessment of anterior segment tumors with ultrasound biomicroscopy
versus anterior segment optical coherence tomography in 200 cases.
Ophthalmology. 118:1297–1302. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Solnik M, Paduszyńska N, Czarnecka AM,
Synoradzki KJ, Yousef YA, Chorągiewicz T, Rejdak R, Toro MD,
Zweifel S, Dyndor K and Fiedorowicz M: Imaging of uveal
melanoma-current standard and methods in development. Cancers
(Basel). 14:31472022. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
National Comprehensive Cancer Network, .
NCCN Clinical Practice Guidelines in Oncology (NCCN
Guidelines®). Small Cell Lung Cancer. Version 1.2025.
2025.
|
|
41
|
Horn L, Mansfield AS, Szczesna A, Havel L,
Krzakowski M, Hochmair MJ and Huemer F: IMpower133: Updated overall
survival (OS) analysis of first-line atezolizumab plus carboplatin
and etoposide in extensive-stage SCLC. Ann Oncol. 30 (Suppl
5):v7132019.
|
|
42
|
Liu SV, Reck M, Mansfield AS, Mok T,
Scherpereel A, Reinmuth N, Garassino MC, De Castro Carpeno J,
Califano R, Nishio M, et al: Updated overall survival and PD-L1
subgroup analysis of patients with extensive-stage small-cell lung
cancer treated with atezolizumab, carboplatin, and etoposide
(IMpower133). J Clin Oncol. 39:619–630. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li H, Han H, Li C, Wu R, Wang Z, Wang Y,
Zhan P, Lv T, Zhang F, Song Y and Liu H: Efficacy and safety of
first-line PD-1/PD-L1 inhibitor combinations for extensive-stage
small-cell lung cancer: A Bayesian network meta-analysis. Ther Adv
Med Oncol. Oct 24–2023.(Epub ahead of print). View Article : Google Scholar
|
|
44
|
Paz-Ares L, Dvorkin M, Chen Y, Reinmuth N,
Hotta K, Trukhin D, Statsenko G, Hochmair MJ, Özgüroğlu M, Ji JH,
et al: Durvalumab plus platinum-etoposide versus platinum-etoposide
in first-line treatment of extensive-stage small-cell lung cancer
(CASPIAN): A randomised, controlled, open-label, phase 3 trial.
Lancet. 394:1929–1939. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Xie Z, Liu J, Wu M, Wang X, Lu Y, Han C,
Cong L, Li J and Meng X: Real-world efficacy and safety of thoracic
radiotherapy after first-line chemo-immunotherapy in
extensive-stage small-cell lung cancer. J Clin Med. 12:38282023.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hetta HF, Aljohani HM, Sirag N, Elfadil H,
Salama A, Al-Twalhy R, Alanazi D, Al-Johani MD, Albalawi JH,
Al-Otaibi RM, et al: Synergizing success: The role of anlotinib
combinations in advanced non-small cell lung cancer treatment.
Pharmaceuticals (Basel). 18:5852025. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Sun J, Ren S, Zhao Q, He J, Wang Y and Ren
M: Endostatin-based anti-angiogenic therapy and immune modulation:
Mechanisms and synergistic potential in cancer treatment. Front
Immunol. 16:16238592025. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Liu M, Qiu G, Guan W, Xie X, Lin X, Xie Z,
Zhang J, Qin Y, Du H, Chen X, et al: Induction chemotherapy
followed by camrelizumab plus apatinib and chemotherapy as
first-line treatment for extensive-stage small-cell lung cancer: A
multicenter, single-arm trial. Signal Transduct Target Ther.
10:652025. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Cheng Y, Chen J, Zhang W, Xie C, Hu Q,
Zhou N, Huang C, Wei S, Sun H, Li X, et al: Benmelstobart,
anlotinib and chemotherapy in extensive-stage small-cell lung
cancer: A randomized phase 3 trial. Nat Med. 30:2967–2976. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Thariat J, Boudin L, Loria O, Nguyen AM,
Kodjikian L and Mathis T: How to manage a patient with ocular
metastases? Biomedicines. 10:30442022. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Schmelter V, Heidorn S, Fuerweger C,
Muacevic A, Priglinger SG, Foerster P and Liegl R: Robotic assisted
CyberKnife radiosurgery for the treatment of choroidal metastasis.
Eye (Lond). 35:3376–3383. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Lin IH, Kuo BI and Liu FY: Adjuvant
intravitreal bevacizumab injection for choroidal and orbital
metastases of refractory invasive ductal carcinoma of the breast.
Medicina (Kaunas). 57:4042021. View Article : Google Scholar : PubMed/NCBI
|
